skip to main content
訪客
個人書架
我的帳戶
登出
登入
This feature requires javascript
檢索首頁
圖書館首頁
電子期刊
引用參考文獻查詢
指定參考書查詢
新書通報
標籤查詢
線上輔助
語言:
English
繁體中文
This feature required javascript
This feature requires javascript
Primo Search
館藏+文章
館藏+文章
館藏
查館藏
文章
查文章
機構典藏
機構典藏
Search For:
Clear Search Box
Search in:
館藏+文章
Or hit Enter to replace search target
Or select another collection:
Search in:
館藏+文章
進階檢索
瀏覽查詢
This feature requires javascript
資源種類
criteria input
圖書
期刊
視聽資料
全部館藏
顯示結果:
criteria input
包含在我的檢索語句內
完全相同
起始以
顯示結果:
查詢種類 索引
criteria input
任何地方
題名
ISBN
ISSN
Show Results with:
題名
Show Results with:
任何地方
題名
ISBN
ISSN
This feature requires javascript
Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?
Cannon, Michael J. ;
Griffiths
,
Paul
D. ; Aston, Van ; Rawlinson, William D.
Reviews in medical virology, 2014-09, Vol.24 (5), p.291-307
[同儕審閱期刊]
可取得全文
引用
被引用
線上檢視
詳細格式
評論和標籤
相關文章推薦
FullText@NUTN
引用次數
This feature requires javascript
傳送到
加入個人書架
從個人書架中移除
E-mail
列印
永久連結
引用
EndNote
導出 RiS
This feature requires javascript
題名:
Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?
著者:
Cannon, Michael J.
;
Griffiths
,
Paul
D.
;
Aston, Van
;
Rawlinson, William D.
主題:
Cytomegalovirus
;
Cytomegalovirus Infections - complications
;
Cytomegalovirus Infections - congenital
;
Cytomegalovirus Infections - diagnosis
;
Cytomegalovirus Infections - virology
;
Humans
;
Infant, Newborn
;
Neonatal Screening
所屬期刊:
Reviews in medical virology, 2014-09, Vol.24 (5), p.291-307
描述:
SUMMARY Congenital CMV infection is a leading cause of childhood disability. Many children born with congenital CMV infection are asymptomatic or have nonspecific symptoms and therefore are typically not diagnosed. A strategy of newborn CMV screening could allow for early detection and intervention to improve clinical outcomes. Interventions might include antiviral drugs or nonpharmaceutical therapies such as speech‐language therapy or cochlear implants. Using published data from developed countries, we analyzed existing evidence of potential benefit that could result from newborn CMV screening. We first estimated the numbers of children with the most important CMV‐related disabilities (i.e. hearing loss, cognitive deficit, and vision impairment), including the age at which the disabilities occur. Then, for each of the disabilities, we examined the existing evidence for the effectiveness of various interventions. We concluded that there is good evidence of potential benefit from nonpharmaceutical interventions for children with delayed hearing loss that occurs by 9 months of age. Similarly, we concluded that there is fair evidence of potential benefit from antiviral therapy for children with hearing loss at birth and from nonpharmaceutical interventions for children with delayed hearing loss occurring between 9 and 24 months of age and for children with CMV‐related cognitive deficits. We found poor evidence of potential benefit for children with delayed hearing loss occurring after 24 months of age and for children with vision impairment. Overall, we estimated that in the United States, several thousand children with congenital CMV could benefit each year from newborn CMV screening, early detection, and interventions. Copyright © 2014 John Wiley & Sons, Ltd.
出版者:
England: Blackwell Publishing Ltd
語言:
英文
識別號:
ISSN: 1052-9276
EISSN: 1099-1654
DOI: 10.1002/rmv.1790
PMID: 24760655
資源來源:
Wiley Online Library All Journals
Wiley Online Library Full Collection 2020
連結
View this record in MEDLINE/PubMed
This feature requires javascript
This feature requires javascript
返回到檢索清單
This feature requires javascript
This feature requires javascript
正在檢索遠程資料庫,請稍等
查詢:
在
scope:("NUTN"),scope:(NUTN_ALEPH),scope:(NUTN_IR),scope:(NUTN_SFX),primo_central_multiple_fe
顯示現有記錄
This feature requires javascript
This feature requires javascript